GMAB peer analysis

Genmab (GMAB) against its competitors: price, today's move, 1-year return and market value side by side.

GMAB and its peers

CompanyPriceToday1-year returnMarket cap
ADCT ADC Therapeutics$1.28-1.54%-68.16%$180.05M
ALXO ALX Oncology$1.063.92%-27.89%$137.03M
BNTX BioNTech$81.00-0.47%-20.14%$20.08B
CGEN Compugen$1.88-4.08%17.50%$178.08M
EXEL Exelixis$63.57-3.43%50.85%$15.98B
INCY Incyte Genomics$113.91-1.69%12.43%$23.22B
IOVA Iovance$6.99-4.43%209.12%$3.23B
LEGN Legend Biotech$15.44-4.10%-44.86%$2.86B
MGNX MacroGenics$1.98-0.01%39.43%$126.53M
RCUS Arcus Biosciences$15.50-1.77%-23.34%$2.23B
GMAB Genmab$50.02-2.59%63.62%$30.84B